This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, W.-W. Articles by Bertino, J. R. Search for Related Content PubMed PubMed Citation Articles by Li, W.-W. Articles by Bertino, J. R.

Intrinsic Resistance to Methotrexate in Human Soft Tissue Sarcoma Cell Lines¹

The Laboratories of Molecular Pharmacology [W. W. L., J. T. L., B. I. S., W. P. T., J. R. B.] and Biostatistics [D. N.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021

A human fibrosarcoma cell line, HT-1080, and four new cell lines (HS-16, HS-28, HS-30, and HS-42) were established from untreated patients with mesenchymal chondrosarcoma, peripheral nerve sheath sarcoma, malignant hemangiopericytoma, and mixed mesodermal tumor, respectively, and were used for analysis of mechanisms of intrinsic resistance to methotrexate. All four new cell lines were resistant to methotrexate as determined by inhibition of thymidylate synthase in whole cells and by growth inhibition, as compared with HT-1080, a methotrexate sensitive cell line. Methotrexate uptake, level of dihydrofolate reductase, and inhibition of this enzyme by methotrexate in the four cell lines were comparable to HT-1080 cells. However, levels of long chain polyglutamates (glu_3-5) of methotrexate achieved after a 24-h incubation with this drug were much lower in the four new cell lines as compared to the HT-1080 cell line (5- to 20-fold lower). The low levels of methotrexate polyglutamates formed is likely the major cause of intrinsic methotrexate resistance in these new sarcoma cell lines.

¹ Supported by Grant CA-47179.

² Present address: Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06510.

³ American Cancer Society Professor of Medicine and Pharmacology. To whom requests for reprints should be addressed.

Received 3/26/92. Accepted 5/ 7/92.

This article has been cited by other articles:

				W. M. Spees, T. P.F. Gade, G. Yang, W. P. Tong, W. G. Bornmann, R. Gorlick, and J. A. Koutcher An 19F Magnetic Resonance-Based In Vivo Assay of Solid Tumor Methotrexate Resistance: Proof of Principle Clin. Cancer Res., February 15, 2005; 11(4): 1454 - 1461. [Abstract] [Full Text] [PDF]

				M. G. Rots, R. Pieters, G. J. Peters, P. Noordhuis, C. H. van Zantwijk, G. J.L. Kaspers, K. Hahlen, U. Creutzig, A. J.P. Veerman, and G. Jansen Role of Folylpolyglutamate Synthetase and Folylpolyglutamate Hydrolase in Methotrexate Accumulation and Polyglutamylation in Childhood Leukemia Blood, March 1, 1999; 93(5): 1677 - 1683. [Abstract] [Full Text] [PDF]

				M. G. Rots, R. Pieters, G.-J. L. Kaspers, C. H. van Zantwijk, P. Noordhuis, R. Mauritz, A. J.P. Veerman, G. Jansen, and G. J. Peters Differential Methotrexate Resistance in Childhood T- Versus Common/PreB-Acute Lymphoblastic Leukemia Can Be Measured by an In Situ Thymidylate Synthase Inhibition Assay, But Not by the MTT Assay Blood, February 1, 1999; 93(3): 1067 - 1074. [Abstract] [Full Text] [PDF]

				S. J. Freemantle and R. G. Moran Transcription of the Human Folylpoly-gamma -glutamate Synthetase Gene J. Biol. Chem., October 3, 1997; 272(40): 25373 - 25379. [Abstract] [Full Text] [PDF]

				L. Chen, H. Qi, J. Korenberg, T. A. Garrow, Y.-J. Choi, and B. Shane Purification and Properties of Human Cytosolic Folylpoly-gamma -glutamate Synthetase and Organization, Localization, and Differential Splicing of Its Gene J. Biol. Chem., May 31, 1996; 271(22): 13077 - 13087. [Abstract] [Full Text] [PDF]